Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Surfactant protein A in chronic extrinsic allergic alveolitis

Martina Sterclova, Martina Vasakova, Peter Paluch, Milan Paulik
European Respiratory Journal 2012 39: 1543-1544; DOI: 10.1183/09031936.00192111
Martina Sterclova
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: martinasafrankova@seznam.cz
Martina Vasakova
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Paluch
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Milan Paulik
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

To the Editors:

The chronic form of extrinsic allergic alveolitis (EAA) may have some common features with idiopathic pulmonary fibrosis (IPF). The clinical, radiological and histopathological presentation of both diseases may be similar. Surfactant protein (SP)-A can be detected in serum of patients with IPF and concentrations of SP-A were found to be elevated in these patients [1]. The aim of the present study was to compare serum SP-A concentrations in IPF and chronic EAA patients and detect possible relationships between SP-A levels, bronchoalveolar lavage (BAL) fluid differential cell counts, high-resolution computed tomography (HRCT) patterns and pulmonary function tests in both diseases.

13 patients with chronic EAA and seven patients with IPF were enrolled in the retrospective study after informed consent was obtained. The mean±sd age of IPF patients was 63.7±12.4 yrs and the mean±sd age of the EAA group 60.3±11.3 yrs. Only one IPF patient was a smoker, all others were nonsmokers.

All of the enrolled subjects underwent a diagnostic programme including history assessment, physical examination, pulmonary function tests, blood tests including evaluation of SP-A serum concentrations, HRCT of the chest, bronchoscopy with BAL and transbronchial biopsy. HRCT alveolar and interstitial scores were assessed according to the criteria of Gay et al. [2] by a pneumologist experienced in radiology.

Patients with IPF who fulfilled diagnostic criteria presented in the official American Thoracic Society/European Respiratory Society/Japanese Respiratory Society/Latin American Thoracic Association statement were included [3]. There are no widely accepted diagnostic criteria for chronic EAA, so data obtained by aforementioned procedures have to be evaluated with care.

Serum samples were collected in the same month as pulmonary function tests and HRCT of the chest were performed. Serum SP-A concentrations were measured according to manufacturer’s instructions (Human Surfactant Protein A ELISA; BioVendor, Brno, Czech Republic).

Results are expressed as mean±SD. Differences between two variables were assessed with the Mann–Whitney U-test. p-values <0.05 were regarded as significant. Spearman’s correlation was used to analyse correlations between pulmonary functions, HRCT scores and SP-A serum concentrations.

Pulmonary function tests, HRCT scores, BAL fluid samples and SP-A serum concentrations are summarised in table 1.

View this table:
  • View inline
  • View popup
Table 1– Pulmonary function tests, high-resolution computed tomography (HRCT) scores, bronchoalveolar lavage results and surfactant protein (SP)-A concentrations in patients with idiopathic pulmonary fibrosis (IPF) and extrinsic allergic alveolitis (EAA)

We found negative correlation between forced vital capacity (FVC) and SP-A serum concentrations in IPF patients (p<0.01). The chronic EAA group exhibited negative correlation between FVC (p<0.05), diffusing capacity of the lung for carbon monoxide (DL,CO) (p<0.01) and BAL fluid eosinophils, and positive correlation between HRCT interstitial score and BAL fluid eosinophils (p<0.01).

While the radiological pattern of IPF should not contain extensive areas of ground-glass opacities, these might be present in chronic EAA patients and usually represent potentially reversible alveolitis indicating continuous exposure to inhalation antigen. Tillie-Leblond et al. [4] presented, in their recent study, patients with chronic progressive EAA presenting with ground-glass opacities on HRCT scans. In accordance with IPF radiological definition, we found significantly lower HRCT alveolar score in the IPF group than in chronic EAA patients (p<0.01). Interstitial score did not differ between both groups, giving evidence for similar extent of fibrotic changes.

Despite the fact that chronic EAA patients showed more advanced deterioration on HRCT, they had significantly higher DL,CO than IPF patients (p<0.01). DL,CO is also influenced by alveolar volume, which is known to be reduced in IPF patients. We found no difference in DL,CO when adjusted for alveolar volume between both groups.

In EAA histology specimens, staining for SP-A was positive in the cytoplasm of all regenerating alveolar epithelial cells, in Clara cells and in elastic fibres in vascular walls. Areas of impaired pulmonary structure showed SP-A positivity in endothelial cells of lymph vessels as well as their contents [5]. We detected no significant difference between serum SP-A levels in chronic EAA and IPF patients which, together with similar HRCT interstitial involvement, may suggest similar alveolar epithelial cell behaviour in both diseases. It is possible that, in chronic EAA, derivation of SP-A from hyperplastic alveolar epithelial cells into the serum by lymphatic vessels may contribute to serum SP-A presence. Mazur et al. [6] recently found that plasma SP-A levels are associated with age and smoking history. SP-A is expressed mostly in alveolar epithelium in nonsmokers, while in smokers the locations differ and SP-A is expressed in bronchial epithelium as well. As both the IPF and EAA groups did not significantly differ in age and only one enrolled patient was a current smoker, these factors do not interfere with the present study.

No correlations among serum SP-A concentrations, pulmonary function tests and HRCT patterns were found. It could be simply explained by the fact that fibrosis and inflammation do not reflect only the activation status of alveolar epithelial cells. Moreover, immunohistochemical studies found that the number of alveolar epithelial cells expressing SP-A varies, ranging from cases in which almost all cells expressed SP-A to cases in which expression was scarce. Because SP-A serum levels and either pulmonary function tests or degree of HRCT score reflect distinct aspects of the fibroproliferative process, the observed values should not inevitably show a correlation.

Israël-Assayag and Cormier [7] demonstrated that SP-A in EAA may have a direct impact on BAL fluid lymphocytosis. At first they suggested alterations of surfactant immunosuppressive activity at alveolar macrophages, which may lead to lymphocytic alveolitis. Nevertheless, further studies pointed out that EAA patients have impaired lymphosuppressive function of regulatory T-cells, which contributes to lymphocyte accumulation in the lung and maintenance of inflammation [8]. We indeed observed higher lymphocyte BAL fluid percentage in EAA patients with higher SP-A levels, even though it did not reach statistical significance.

Our study shows that SP-A serum concentrations do not differ between chronic EAA and IPF patients and thus should not be used as a biomarker for IPF detection. Prognostic value of serum SP-A concentrations in chronic EAA patients should be the aim of further studies.

Footnotes

  • Statement of Interest

    None declared.

  • ©ERS 2012

REFERENCES

  1. ↵
    1. Goldmann T,
    2. Kähler D,
    3. Schultz H,
    4. et al
    . On the significance of surfactant protein-A within the human lungs. Diagn Pathol 2009; 4: 8.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Gay SE,
    2. Kazerooni EA,
    3. Toews GB,
    4. et al
    . Idiopathic pulmonary fibrosis: predicting response to therapy and survival. Am J Respir Crit Care Med 1998; 157: 1063–1072.
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. Raghu G,
    2. Collard HR,
    3. Egan JJ,
    4. et al
    . An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183: 788–824.
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    1. Tillie-Leblond I,
    2. Grenouillet F,
    3. Reboux G,
    4. et al
    . Hypersensitivity pneumonitis and metalworking fluids contaminated by mycobacteria. Eur Respir J 2011; 37: 640–647.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Ohtsuki Y,
    2. Nakanishi N,
    3. Fujita J,
    4. et al
    . Immunohistochemical distribution of SP-D, compared with that of SP-A and KL-6, in interstitial pneumonias. Med Mol Morphol 2007; 40: 163–167.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Mazur W,
    2. Toljamo T,
    3. Ohlmeier S,
    4. et al
    . Elevation of surfactant protein A in plasma and sputum in cigarette smokers. Eur Respir J 2011; 38: 277–284.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Israël-Assayag E,
    2. Cormier Y
    . Surfactant modifies the lymphoproliferative activity of macrophages in hypersensitivity pneumonitis. Am J Physiol 1997; 273: L1258–L1264.
    OpenUrlPubMed
  8. ↵
    1. Girard M,
    2. Israël-Assayag E,
    3. Cormier Y
    . Impaired function of regulatory T-cells in hypersensitivity pneumonitis. Eur Respir J 2011; 37: 632–639.
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top
View this article with LENS
Vol 39 Issue 6 Table of Contents
European Respiratory Journal: 39 (6)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Surfactant protein A in chronic extrinsic allergic alveolitis
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Surfactant protein A in chronic extrinsic allergic alveolitis
Martina Sterclova, Martina Vasakova, Peter Paluch, Milan Paulik
European Respiratory Journal Jun 2012, 39 (6) 1543-1544; DOI: 10.1183/09031936.00192111

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Surfactant protein A in chronic extrinsic allergic alveolitis
Martina Sterclova, Martina Vasakova, Peter Paluch, Milan Paulik
European Respiratory Journal Jun 2012, 39 (6) 1543-1544; DOI: 10.1183/09031936.00192111
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Interstitial and orphan lung disease
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Obesity in COPD: the effect of water-based exercise
  • Burden of CAP in Italian general practice
  • Neutrophilia independently predicts death in tuberculosis
Show more Letters

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society